Soman- or kainic acid-induced convulsions decrease muscarinic receptors but not benzodiazepine receptors

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Acetylcholinesterase inhibitors like soman and excitotoxins like kainic acid can induce seizures.
• Muscarinic receptors play crucial roles in various brain functions.
• Benzodiazepine receptors are involved in inhibitory neurotransmission.

Purpose of the Study:

• To investigate the impact of soman- or kainic acid-induced convulsions on muscarinic and benzodiazepine receptors in the rat forebrain.
• To determine if receptor number or affinity is affected by convulsive states.
• To compare the vulnerability of muscarinic and benzodiazepine receptors to seizure-induced changes.

Main Methods:

• Induction of convulsions in rats using soman or kainic acid.
• Measurement of [3H]Quinuclidinyl benzilate (QNB) binding to muscarinic receptors.
• Measurement of [3H]flunitrazepam binding to benzodiazepine receptors.
• Analysis of receptor changes using Rosenthal plots.
• Assessment of the effect of blocking convulsions on receptor levels.

Main Results:

• Convulsions significantly decreased [3H]QNB binding, indicating a reduction in muscarinic receptor number, not affinity.
• Blocking soman-induced convulsions attenuated the decrease in muscarinic receptors.
• The piriform cortex showed the most prominent decrease in QNB binding, correlating with neuropathology.
• [3H]flunitrazepam binding to benzodiazepine receptors remained unchanged, even in affected brain areas.

Conclusions:

• The convulsive state leads to down-regulation of muscarinic receptors in specific brain regions.
• Muscarinic receptors are more vulnerable to convulsion-induced changes than benzodiazepine receptors.
• Neuropathology associated with seizures may contribute to receptor loss in areas like the piriform cortex.